Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $61.5 million, down 1% year-over-year, but above the high end of guidance [4][22] - Adjusted EBITDA was $18 million, reflecting a 29% margin, which expanded approximately 120 basis points year-over-year [21][24] - Unlevered Free Cash Flow for the trailing 12 months was approximately $55 million [5][22] - Full year 2025 total revenue was $241.5 million, a 4% decline year-over-year [24] Business Line Data and Key Metrics Changes - Subscription revenues were $58.5 million, down 3% year-over-year, or down 7% excluding data partnership contributions [22] - Professional services revenue increased by 49% year-over-year, driven by traditional analytics engagements and digital activations [22] - Adjusted gross profit margin for Q4 was 82%, expanding about 100 basis points year-over-year [23] Market Data and Key Metrics Changes - Gross dollar retention improved by about 2 points year-over-year, indicating stabilization efforts are taking effect [24][42] - Net dollar retention declined due to ongoing pressure in upsell opportunities [24][43] Company Strategy and Development Direction - The company focuses on four strategic pillars: data differentiation, integrations, customer success, and innovation [6][18] - Plans to enhance data assets and improve integration capabilities to drive customer satisfaction and retention [8][9] - Emphasis on AI as a core enabling technology for growth, leveraging proprietary data for competitive advantage [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to consistent revenue growth despite a challenging macro environment [20][28] - Anticipated improvements in retention and upsell opportunities as new data sources and product innovations are introduced [25][44] - The company expects modest revenue declines in 2026, with a focus on managing costs while investing in growth areas [30][32] Other Important Information - The company has made significant progress in remediating claims data disruptions, restoring data volumes to above historical levels [7][76] - The integration of GenAI into products is expected to enhance customer engagement and unlock new use cases [17][56] Q&A Session Summary Question: Update on demand environment across end markets - Management noted improvements in retention trends and sales cycles, with a focus on data quality and integrations driving positive outcomes [36][38] Question: Insights on renewal cycles and end market performance - Management highlighted improvements in gross dollar retention, particularly among enterprise customers in the life sciences sector, while noting challenges in net dollar retention due to upsell pressures [42][43] Question: Impact of AI on customer conversations and budget allocation - Management emphasized that AI is seen as a competitive advantage, enhancing existing workflows rather than detracting from traditional vendors [50][51] Question: Expectations for net dollar retention recovery - Management expects net dollar retention to improve in 2026, viewing 2025 as the bottom for this metric [55][78] Question: Dynamics in the life sciences end market - Management reported consistent engagement and high retention rates in the life sciences space, with a focus on stabilizing revenue amid down-sell pressures [84]

Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $61.5 million, down 1% year-over-year, but above the high end of guidance [3][21] - Adjusted EBITDA was $18.1 million, representing a margin of 29%, which was $1.1 million above the high end of guidance [3][4] - Adjusted net income was $8.6 million, resulting in $0.06 of non-GAAP earnings per share [21] - Unlevered Free Cash Flow for the trailing 12 months was approximately $55 million [4] Business Line Data and Key Metrics Changes - Subscription revenues were $58.5 million, down 3% year-over-year, or down 7% excluding data partnership contributions [22] - Professional services revenue increased by 49% year-over-year, driven by traditional analytics engagements and ramp-up in digital activations [22] - Adjusted gross profit was $50.2 million, flat from Q4 2024, with an adjusted gross profit margin of 82%, expanding about 100 basis points year-over-year [23] Market Data and Key Metrics Changes - Gross dollar retention improved by about 2 points year-over-year, reflecting initial impacts of actions taken to stabilize the business [24] - Net dollar retention declined due to ongoing pressure in upsell opportunities [24] Company Strategy and Development Direction - The company focuses on four strategic pillars: data differentiation, integrations, customer success, and innovation [4][19] - Plans to invest in areas showing promise, particularly digital activation and partnerships, while maintaining strong margins [19][32] - The company aims to return to consistent revenue growth, with a focus on improving retention [19][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the remediation of claims data disruption and its positive impact on performance moving into 2026 [36][44] - The macro environment remains challenging, but the company will focus on controllable areas and necessary investments to improve operational performance [19][32] - Management expects to see improvements in net dollar retention in 2026, viewing 2025 as the bottom [55][78] Other Important Information - The company capitalized about $6 million in software development spend, a $5 million increase over the prior year [26] - Deferred revenue was $99 million, up 6% year-over-year, while total remaining performance obligations declined 18% year-over-year [27] Q&A Session Summary Question: Update on demand environment across end markets - Management noted improvements in retention trends and confidence in the strategy focused on data quality and integrations [36][37] Question: Insights on renewal cycles across end markets - Management highlighted improvements in gross dollar retention driven by enterprise customers, particularly in life sciences [42][43] Question: Impact of AI on customer conversations - Management emphasized that AI is seen as a competitive advantage, enhancing existing workflows and use cases [51][53] Question: Expectations for net dollar retention improvement - Management expects modest improvement in net dollar retention in 2026, with confidence in product innovation and data remediation efforts [55][78] Question: Dynamics in the life sciences end market - Management reported stabilization in gross dollar retention and ongoing engagement with long-standing relationships in the life sciences space [84][85] Question: Return on organic innovation spend - Management indicated that product releases are expected to ramp up in Q2, with ongoing focus on AI-enabled product development [87]

Definitive Healthcare FY Conference Summary Company Overview - **Company**: Definitive Healthcare (NasdaqGS:DH) - **Industry**: Healthcare market data and analytics - **Business Model**: Proprietary SaaS platform serving three customer groups: life sciences, healthcare providers, and diversified clients [5][6] Key Financial Metrics - **Recurring Revenue**: Approximately 95% of revenue is recurring [6] - **Adjusted EBITDA Margins**: High 20s percentage [6] - **Cash Flow Conversion**: Vast majority of Adjusted EBIT converted into cash flow [6] Strategic Pillars 1. **Data Differentiation** - Focus on reference and affiliation data as a foundational component for understanding the healthcare ecosystem [12] - New data sets added, including mobile phone numbers for healthcare executives and new claims data sources [12][13] - Significant KPI tracking implemented to measure data quality and completeness [13] 2. **Seamless Integration** - Progress made in integrating acquired companies into a unified platform [19] - Customer retention rates are approximately 15 points higher for integrated customers [20] - New integrations launched, including HubSpot and additional physician data into Salesforce [20][21] 3. **Customer Success** - Focus on improving customer engagement and retention metrics [25] - Customer success incentive plans aligned with gross and net dollar retention [26] - Win-back strategy for previous customers, emphasizing value-based selling [28][29] 4. **Innovation and Digital Partnerships** - Generative AI is a key focus area for both internal operations and product development [30][33] - Agency partnerships have grown to about 23, with ongoing activations [36][38] - Emphasis on leveraging agency relationships to expand market reach [40][41] Market Segments - **Revenue Breakdown**: 40% from life sciences, 10% from providers, and 50% from diversified clients [45] - **Life Sciences Challenges**: Cautious outlook due to budgetary constraints and downsell pressures [45][46] - **Sales Cycle Trends**: Notable tightening of sales cycles observed, indicating potential for improved demand [46] Capital Allocation Strategy - **Cash Position**: Over $185 million in cash on the balance sheet, with net zero leverage [61] - **Investment Focus**: Prioritizing organic investments that strengthen core offerings and enhance customer value [61][62] - **M&A Strategy**: High bar for future acquisitions, with a focus on adjacent growth areas [62] Additional Insights - **Operational Efficiency**: Continuous evaluation of operational expenses, particularly in G&A and sales/marketing [56][57] - **AI Utilization**: Exploring AI tools to improve productivity and customer engagement [54][55] - **Customer Engagement**: Emphasis on understanding customer health scores and engagement levels to drive retention [27] This summary encapsulates the key points discussed during the Definitive Healthcare FY Conference, highlighting the company's strategic focus, financial metrics, and market dynamics.